Development of an mRNA-lipid nanoparticle vaccine against Lyme disease
Pardi and colleagues developed a nucleoside-modified mRNA vaccine against Lyme disease. The OspA-targeting vaccine induced robust T cell, germinal center B cell, memory B cell, long-lived plasma...
cell.com